GlassScriptPhysician profile
Jeffery Kuhn
NPI 1891809448
$1,016.43
in general payments reported to CMS, 2019-2025
13 companies · $82.62 in 2025
The $82.62 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.06 · 2021: $49.73 · 2022: $234 · 2023: $585 · 2024: $48.43 · 2025: $82.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $418.95 | 2022-2023 | |
| Lundbeck LLC | $213.60 | 2023-2024 | Vyepti |
| Regeneron Healthcare Solutions, INC. | $69.48 | 2021-2023 | Dupixent |
| Biohaven Pharmaceutical Holding Company LTD. | $56.20 | 2022 | |
| Iotamotion, INC. | $55.63 | 2025 | Iotasoft |
| Inspire Medical Systems, INC. | $51.65 | 2023 | Inspire |
| Pfizer INC. | $28.41 | 2023-2024 | |
| Med-El Corporation | $26.99 | 2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Amgen INC. | $23.72 | 2023 | Aimovig |
| Genzyme Corporation | $23.08 | 2022 | |
| Glaxosmithkline, LLC. | $17.56 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.06 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Kuhn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.